Q3 2025 Earnings Call Transcript November 4, 2025 Rigel Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1 ...
Q3 2025 Earnings Call Transcript November 3, 2025 Ares Management Corporation beats earnings expectations. Reported EPS is $1 ...
To address the specific challenges faced by older adults with inflammatory bowel disease (IBD), UCSF Health created the UCSF ...
GLP-1RA use, compared with basal insulin and DPP-4i use, was associated with lower risks for IBD and hospitalization in type 2 diabetes.
Average dietary fiber intake is lower among patients with active vs inactive inflammatory bowel disease, particularly among ...
SPY003 was well tolerated and exhibited an ~85-day half-life, supporting potential quarterly or twice annual maintenance ...
Teva Pharmaceutical Industries Ltd (TEVA) reports its 11th consecutive quarter of growth, driven by innovative products, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback